newsfilter
← Latest News
GlobeNewswire·

Brickell Biotech Increases Previously Announced Bought Deal Offering of Common Stock to $7.0 Million

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (NASDAQ:BBI) (the "Company" or "Brickell"), clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment o